Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders

In recent times, advances in the field of metabolomics have shed greater light on the role of metabolic disturbances in neuropsychiatric conditions. The following review explores the role of ketone bodies and ketosis in both the diagnosis and treatment of three major psychiatric disorders: major dep...

Full description

Bibliographic Details
Main Authors: Naomi Elyse Omori, Mantas Kazimieras Malys, Geoffrey Woo, Latt Mansor
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1142682/full
_version_ 1797845608738848768
author Naomi Elyse Omori
Mantas Kazimieras Malys
Geoffrey Woo
Latt Mansor
author_facet Naomi Elyse Omori
Mantas Kazimieras Malys
Geoffrey Woo
Latt Mansor
author_sort Naomi Elyse Omori
collection DOAJ
description In recent times, advances in the field of metabolomics have shed greater light on the role of metabolic disturbances in neuropsychiatric conditions. The following review explores the role of ketone bodies and ketosis in both the diagnosis and treatment of three major psychiatric disorders: major depressive disorder, anxiety disorders, and schizophrenia. Distinction is made between the potential therapeutic effects of the ketogenic diet and exogenous ketone preparations, as exogenous ketones in particular offer a standardized, reproducible manner for inducing ketosis. Compelling associations between symptoms of mental distress and dysregulation in central nervous system ketone metabolism have been demonstrated in preclinical studies with putative neuroprotective effects of ketone bodies being elucidated, including effects on inflammasomes and the promotion of neurogenesis in the central nervous system. Despite emerging pre-clinical data, clinical research on ketone body effectiveness as a treatment option for psychiatric disorders remains lacking. This gap in understanding warrants further investigating, especially considering that safe and acceptable ways of inducing ketosis are readily available.
first_indexed 2024-04-09T17:41:46Z
format Article
id doaj.art-7e6071dfe0c742c5937680fc2c25d232
institution Directory Open Access Journal
issn 1664-0640
language English
last_indexed 2024-04-09T17:41:46Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj.art-7e6071dfe0c742c5937680fc2c25d2322023-04-17T05:00:03ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402023-04-011410.3389/fpsyt.2023.11426821142682Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disordersNaomi Elyse Omori0Mantas Kazimieras Malys1Geoffrey Woo2Latt Mansor3Health Via Modern Nutrition Inc. (H.V.M.N.), San Francisco, CA, United StatesDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College, London, United KingdomHealth Via Modern Nutrition Inc. (H.V.M.N.), San Francisco, CA, United StatesHealth Via Modern Nutrition Inc. (H.V.M.N.), San Francisco, CA, United StatesIn recent times, advances in the field of metabolomics have shed greater light on the role of metabolic disturbances in neuropsychiatric conditions. The following review explores the role of ketone bodies and ketosis in both the diagnosis and treatment of three major psychiatric disorders: major depressive disorder, anxiety disorders, and schizophrenia. Distinction is made between the potential therapeutic effects of the ketogenic diet and exogenous ketone preparations, as exogenous ketones in particular offer a standardized, reproducible manner for inducing ketosis. Compelling associations between symptoms of mental distress and dysregulation in central nervous system ketone metabolism have been demonstrated in preclinical studies with putative neuroprotective effects of ketone bodies being elucidated, including effects on inflammasomes and the promotion of neurogenesis in the central nervous system. Despite emerging pre-clinical data, clinical research on ketone body effectiveness as a treatment option for psychiatric disorders remains lacking. This gap in understanding warrants further investigating, especially considering that safe and acceptable ways of inducing ketosis are readily available.https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1142682/fullketoneBHBβ-hydroxybutyric acidanxietydepressionschizophrenia
spellingShingle Naomi Elyse Omori
Mantas Kazimieras Malys
Geoffrey Woo
Latt Mansor
Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
Frontiers in Psychiatry
ketone
BHB
β-hydroxybutyric acid
anxiety
depression
schizophrenia
title Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
title_full Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
title_fullStr Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
title_full_unstemmed Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
title_short Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
title_sort exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
topic ketone
BHB
β-hydroxybutyric acid
anxiety
depression
schizophrenia
url https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1142682/full
work_keys_str_mv AT naomielyseomori exploringtheroleofketonebodiesinthediagnosisandtreatmentofpsychiatricdisorders
AT mantaskazimierasmalys exploringtheroleofketonebodiesinthediagnosisandtreatmentofpsychiatricdisorders
AT geoffreywoo exploringtheroleofketonebodiesinthediagnosisandtreatmentofpsychiatricdisorders
AT lattmansor exploringtheroleofketonebodiesinthediagnosisandtreatmentofpsychiatricdisorders